Table 6.
OR* | 95% CI | PARP(%) | |
Han | |||
Men (BF%≥24%) | |||
Hypertension | 3.680 | 2.728 to 4.964 | 53.8 |
Diabetes | 1.479 | 0.940 to 2.328 | 17.2 |
Dyslipidaemia | 2.966 | 2.251 to 3.908 | 46.1 |
Risk factors ≥2 | 3.450 | 2.490 to 4.780 | 51.6 |
Women (BF%≥34%) | |||
Hypertension | 3.382 | 2.544 to 4.494 | 51.8 |
Diabetes | 2.660 | 1.539 to 4.596 | 42.8 |
Dyslipidaemia | 3.152 | 2.439 to 4.072 | 49.3 |
Risk factors ≥2 | 4.016 | 2.682 to 6.014 | 57.6 |
Mongolian | |||
Men (BF%≥25%) | |||
Hypertension | 2.587 | 1.635 to 4.094 | 42.2 |
Diabetes | 2.982 | 1.374 to 6.471 | 47.6 |
Dyslipidaemia | 2.986 | 1.930 to 4.620 | 47.7 |
Risk factors≥2 | 3.772 | 2.251 to 6.321 | 56.0 |
Women (BF%≥35%) | |||
Hypertension | 2.851 | 1.796 to 4.526 | 46.5 |
Diabetes | 2.061 | 0.634 to 6.697 | 33.3 |
Dyslipidaemia | 2.599 | 1.704 to 3.964 | 42.9 |
Risk factors≥2 | 4.882 | 2.497 to 9.545 | 64.6 |
*Adjusted ORs for CVDs in subjects using sex-specific cut-offs for BF%, adjusted for age.
BF%, body fat percentage; CVD, cardiovascular disease; PARP, population attributable risk proportion.